Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: An experimental study in obese rats

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 11, 2009, Pages 900-907

  Chudasama, H P ^a   Bhatt, P A ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Anti depressant activity; Anti obesity activity; Duloxetine; HFD; Hypothalamic pituitary axis (HPA); Sibutramine; SNRIs

Indexed keywords

DULOXETINE; NORADRENALIN; SEROTONIN; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; EVALUATION; EXPERIMENTAL TEST; FOOD INTAKE; FORCED SWIMMING TEST; LOCOMOTION; MALE; NONHUMAN; OBESITY; OPEN FIELD TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; TAIL SUSPENSION TEST;

ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; ANTIDEPRESSIVE AGENTS; APPETITE REGULATION; BLOOD PRESSURE; BODY TEMPERATURE REGULATION; BODY WEIGHT; CYCLOBUTANES; DEPRESSION; DIET; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; MALE; MOTOR ACTIVITY; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; SATIETY RESPONSE; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 74849122322     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-080     Document Type: Article

References (43)

1. Agabiti-Rosei, E., Alicandri, C., Beschi, M., Castellano, M., Corea, L., Beggi, P., et al. 1983. Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension. Cardiology, 70(6): 308-316. doi:10.1159/000173613. PMID:6370432.
2. Boozer, C.N., Schoenbach, G., and Atkinson, R.L. 1995. Dietary fat and adiposity: a dose-response relationship in adult male rats fed isocalorically. American physiological society: E546-E5450.
3. Buettner, R., Schölmerich, J., and Bollheimer, L.C. 2007. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring), 15(4): 798-808. doi:10.1038/oby.2007.608. PMID:17426312.
4. Carter, F.A., Bulik, C.M., and Joyce, P.R. 1994. Direction of weight change in depression. J. Affect. Disord. 30(1): 57-60. doi:10.1016/0165-0327(94)90151-1. PMID:8151050.
5. Chermat, R., Thierry, B., Mico, J.A., Steru, L., and Simon, P. 1986. Adaptation of the tail suspension test to the rat. J. Pharmacol. 17(3): 348-350. PMID:3795979.
6. Connoley, I.P., Liu, Y.L., Frost, I., Reckless, I.P., Heal, D.J., and Stock, M.J. 1999. Thermogenic effects of sibutramine and its metabolites. Br. J. Pharmacol. 126(6): 1487-1495. doi:10.1038/sj.bjp.0702446. PMID:10217544.
7. de Zwaan, M. 2001. Binge eating disorder and obesity. Int. J. Obes. Relat. Metab. Disord. 25(Suppl 1): S51-S55. doi:10.1038/sj.ijo.0801699. PMID:11466589.
8. Delgado, P.L. 2000. Depression: the case for a monoamine deficiency. J. Clin. Psychiatry, 61(Suppl 6): 7-11. PMID:10775018.
9. Dobrian, A.D., Devies, M.J., Prewitt, R.L., and Lauterio, T.J. 2000. Development of hypertension in a rat model of diet-induced obesity. Hypertension, 35:1009-1015.
10. Ehlert, U., Gaab, J., and Heinrichs, M. 2001. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 57(1-3): 141-152. doi:10.1016/S0301-0511(01)00092- 8. PMID:11454437.
11. Faith, M.S., Matz, P.E., and Jorge, M.A. 2002. Obesity-depression associations in the population. J. Psychosom. Res. 53(4): 935-942. doi:10.1016/S0022-3999(02)00308-2. PMID:12377306.
12. Frazer, A. 1997. Pharmacology of antidepressants. J. Clin. Psychopharmacol. 17(2S Suppl 1): 2S-18S. doi:10.1097/00004714-199704001- 00002. PMID:9090573.
13. Hall, J.E., Brands, M.W., Hildebrandt, D.A., Kuo, J., and Fitzgerald, S. 2000. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Braz. J. Med. Biol. Res. 33(6): 605-618. doi:10.1590/S0100-879X2000000600001. PMID:10829088.
14. Heisler, L.K., Cowley, M.A., Kishi, T., Tecott, L.H., Fan, W., Low, M.J., et al. 2003. Central serotonin and melanocortin pathways regulating energy homeostasis. Ann. N. Y. Acad. Sci. 994(1): 169-174.doi:10.1111/j.1749- 6632.2003.tb03177.x. PMID:12851313.
15. Heisler, L.K., Jobst, E.E., Sutton, G.M., Zhou, L., Borok, E., Thornton-Jones, Z., et al. 2006. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron, 51(2): 239-249. doi:10.1016/j.neuron.2006.06.004. PMID:16846858.
16. Jackson, H.C., Bearham, M.C., Hutchins, L.J., Mazurkiewicz, S.E., Needham, A.M., and Heal, D.J. 1997a. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol. 121(8): 1613-1618. doi:10.1038/sj.bjp.0701311. PMID:9283694.
17. Jackson, H.C., Needham, A.M., Hutchins, L.J., Mazurkiewicz, S.E., and Heal, D.J. 1997b. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol. 121(8): 1758-1762. doi:10.1038/sj.bjp.0701312. PMID:9283714.
18. Kasckow, J.W., Baker, D., and Geracioti, T.D., Jr. 2001. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides, 22(5): 845-851. doi:10.1016/S0196-9781(01)00399-0. PMID:11337099.
19. Katz, J.R., Taylor, N.F., Goodrick, S., Perry, L., Yudkin, J.S., and Coppack, S.W. 2000. Central obesity, depression and the hypothalamo-pituitary- adrenal axis in men and postmenopausal women. Int. J. Obes. Relat. Metab. Disord. 24(2): 246-251. doi:10.1038/sj.ijo.0801122. PMID:10702778.
20. Kim, S.H., Lee, Y.M., Jee, S.H., and Nam, C.M. 2003. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes. Res. 11(9): 1116-1123. doi:10.1038/oby.2003.152. PMID:12972682.
21. Langin, D. 2006. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol. Res. 53(6): 482-491. doi:10.1016/j.phrs.2006.03.009. PMID:16644234.
22. Luque, C.A., and Rey, J.A. 2002. The discovery and status of sibutramine as an anti-obesity drug. Eur. J. Pharmacol. 440(2-3): 119-128. doi:10.1016/S0014-2999(02)01423-1. PMID:12007530.
23. Mazzola-Pomietto, P., Aulakh, C.S., Wozniak, K.M., and Murphy, D.L. 1996. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology (Berl.), 123(4): 333-339. doi:10.1007/BF02246643. PMID:8867872.
24. McElroy, S.L., Kotwal, R., Malhotra, S., Nelson, E.B., Keck, P.E., and Nemeroff, C.B. 2004. Are mood disorders and obesity related? A review for the mental health professional. J. Clin. Psychiatry, 65(5): 634-651, quiz 730. PMID:15163249.
25. Mickelsen, O., Takahashi, S., and Craig, C. 1955. Experimental obesity. I. Production of obesity in rats by feeding high-fat diets. J. Nutr. 57(4): 541-554. PMID:13278777.
26. Musselman, D.L., Evans, D.L., and Nemeroff, C.B. 1998. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry, 55(7): 580-592. doi:10.1001/archpsyc.55.7.580. PMID:9672048.
27. Otobone, F.J., Sela V.R., Obici, S., Moreira, L.Y., Cortez, D.A.G., Audi, E.A. 2007. Role of 5-HT1A receptors in antidepressant-like effect of dichloromethane fraction of Kielmeyera coriacea in rat subjected to the forced swim test. Ind. J. Pharmacol. 39(2): 75-79.
28. Parkes, D.G., Weisinger, R.S., and May, C.N. 2001. Cardiovascular actions of CRH and urocortin: an update. Peptides, 22(5): 821-827. doi:10.1016/S0196-9781(01)00396-5. PMID:11337096.
29. Peckham, S.C., Entenman, C., and Carroll, H.W. 1962. The influence of a hypercalric diet on gross body and adipose tissue composition in the rat. J. Nutr. 77: 187-197. PMID:14484832.
30. Perahia, D.G., Kajdasz, D.K., Walker, D.J., Raskin, J., and Tylee, A. 2006. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Int. J. Clin. Pract. 60(5): 613-620. doi:10.1111/j.1368-5031. 2006.00956.x. PMID:16700869.
31. Porsolt, R.D., Bertin, A., and Jalfre, M. 1977a. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229(2): 327-336. PMID:596982.
32. Porsolt, R.D., Le Pichon, M., and Jalfre, M. 1977b. Depression: a new animal model sensitive to antidepressant treatments. Nature, 266(5604): 730-732. doi:10.1038/266730a0. PMID:559941.
33. Porsolt, R.D., Anton, G., Blavet, N., and Jalfre, M. 1978. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47(4): 379-391. doi:10.1016/0014-2999(78)90118-8. PMID:204499.
34. Raskin, J., Goldstein, D.J., Mallinckrodt, C.H., and Ferguson, M.B. 2003. Duloxetine in the long-term treatment of major depressive disorder. J. Clin. Psychiatry, 64(10): 1237-1244. PMID:14658974.
35. Roberts, R.E., Kaplan, G.A., Shema, S.J., and Strawbridge, W.J. 2000. Are the obese at greater risk for depression? Am. J. Epidemiol. 152(2): 163-170. doi:10.1093/aje/152.2.163. PMID:10909953.
36. Rosmond, R., and Björntorp, P. 2000. The hypothalamic-pituitary- adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 247(2): 188-197. doi:10.1046/j.1365-2796. 2000.00603.x. PMID:10692081.
37. Rowland, N.E., Morien, A., and Li, B.H. 1996. The physiology and brain mechanisms of feeding. Nutrition, 12(9): 626-639. doi:10.1016/S0899- 9007(96)00227-4. PMID:8878173.
38. Ryan, D.H. 2003. Use of sibutramine to treat obesity. Prim. Care, 30(2): 405-426. viii. PMID:14567156.
39. Smith, B.K., York, D.A., and Bray, G.A. 1998a. Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol. Biochem. Behav. 60(1): 105-114. doi:10.1016/S0091-3057(97)00549-2. PMID:9610931.
40. Smith, D.E., Marcus, M.D., Lewis, C.E., Fitzgibbon, M., and Schreiner, P. 1998b. Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann. Behav. Med. 20(3): 227-232. doi:10.1007/BF02884965. PMID:9989331.
41. Stunkard, A.J., Faith, M.S., and Allison, K.C. 2003. Depression and obesity. Biol. Psychiatry, 54(3): 330-337. doi:10.1016/S0006-3223(03) 00608-5. PMID:12893108.
42. Wozniak, K.M., Aulakh, C.S., Hill, J.L., and Murphy, D.L. 1988. The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol. Biochem. Behav. 30(2): 451-456. doi:10.1016/0091-3057(88)90479-0. PMID:2971978.
43. Wozniak, K.M., Aulakh, C.S., Hill, J.L., and Murphy, D.L. 1989. Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology (Berl.), 97(2): 269-274. doi:10.1007/BF00442262. PMID:2498937.